Investigators have developed and validated 2 new fracture risk algorithms for estimating the individual risk of osteoporotic fracture or hip fracture over a 10-year time period.
Investigators have developed and validated 2 new fracture risk algorithms for estimating the individual risk of osteoporotic fracture or hip fracture over a 10-year time period. Researchers used data from more than 2 million male and female patients between the ages of 30 and 85 years from 574 general practices in England and Wales, gleaned over a 15-year period. Two-thirds of practices were allocated to the derivation dataset and the remaining third to the validation dataset (practices from which data were not used to develop the algorithms).
According to the study, reported in the British Medical Journal, osteoporotic fracture risk in women was significantly and independently associated with use of hormone replacement therapy, age, smoking status, alcohol use, parental history of osteoporosis, rheumatoid arthritis, cardiovascular disease, type 2 diabetes, asthma, use of tricyclic antidepressants or corticosteroids, history of falls, menopausal symptoms, chronic liver disease, gastrointestinal malabsorption, and other endocrine disorders. However, not all of these variables were associated with risk of hip fracture.
Because the algorithms can predict fracture risk without laboratory measurements, they are suitable in both clinical settings and for self-assessment. A questionnaire and calculator of 10-year risk for osteoporotic fracture or hip fracture based on the algorithms are available at http://www.qfracture.org/.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More